DexCom (DXCM) r&d spend was $599M in FY2025 (+8% YoY). The tables below show the complete quarterly and annual r&d spend history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual R&D Spend
Fiscal Year
R&D Spend
YoY
2025
$599M
+8%
2024
$552M
+9%
2023
$506M
+4%
2022
$484M
-6%
2021
$517M
+44%
2020
$360M
+32%
2019
$274M
+37%
2018
$200M
+8%
2017
$185M
+19%
2016
$156M
+14%
2015
$138M
+98%
2014
$69M
+55%
2013
$45M
+17%
2012
$38M
+29%
2011
$30M
+28%
2010
$23M
+62%
2009
$14M
Recent Quarterly R&D Spend
Quarter
R&D Spend
Q1 2026
$145M
Q4 2025
$148M
Q3 2025
$158M
Q2 2025
$148M
Q1 2025
$145M
Q4 2024
$140M
Q3 2024
$135M
Q2 2024
$136M
Q1 2024
$142M
Q4 2023
$136M
Q3 2023
$131M
Q2 2023
$119M
Source: DXCM on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.